```html

Quincy Disease (Congenital Hypothyroidism)

Overview

Quincy disease is an historic eponym that refers to congenital hypothyroidism (CH), a condition in which the thyroid gland fails to produce enough thyroid hormone during fetal development or shortly after birth. Thyroid hormone is essential for brain development, growth, and metabolism, so a deficiency can have serious consequences if not identified and treated promptly.

CH occurs in 1 in 2,000 to 1 in 4,000 newborns worldwide (CDC, 2022). It affects both sexes equally, although certain genetic causes are more common in specific ethnic groups.

Because most infants with CH appear healthy at birth, many countries have instituted universal newborn screening programs. Early detection and treatment have dramatically improved outcomes; children diagnosed and treated within the first two weeks of life have normal intelligence and growth in >95% of cases (Mayo Clinic, 2023).

Symptoms

Symptoms of congenital hypothyroidism may be subtle at birth and can develop over weeks or months. The classic “cretinism” picture—severe developmental delay, dwarfism, and coarse facial features—represents untreated, long‑standing disease and is now rare in regions with newborn screening.

Neonatal (first weeks of life)

• Prolonged jaundice – bilirubin levels stay high beyond the normal 2–3 days.
• Feeding difficulties – poor suck, lethargy, or a weak cry.
• Hypothermia – difficulty maintaining body temperature.
• Umbilical hernia – a soft bulge at the navel.
• Enlarged tongue (macroglossia) and a “puffy” face.
• Constipation due to slowed gut motility.

Infancy (1–12 months)

• Slow weight gain or weight loss despite adequate feeding.
• Developmental delay – milestones such as rolling, sitting, or babbling are reached later.
• Dry, coarse skin and hair; hair may be sparse or brittle.
• Muscle hypotonia (floppiness) and reduced reflexes.
• Enlarged liver or spleen (hepatosplenomegaly) in severe cases.

Older infants & toddlers (1–3 years)

• Short stature (height markedly below the 5th percentile).
• Delayed speech and intellectual development.
• Delayed tooth eruption and dental abnormalities.
• Persistent constipation.
• Elevated cholesterol levels.

Causes and Risk Factors

Congenital hypothyroidism can be divided into two broad categories: thyroid dysgenesis (structural problems) and dyshormonogenesis (enzyme defects). Approximately 85% of cases are due to dysgenesis; the remaining 15% result from dyshormonogenesis or transient causes.

Thyroid Dysgenesis (≈85% of cases)

• Ectopic thyroid tissue – the gland is located in an abnormal position (often at the base of the tongue).
• Thyroid agenesis – complete absence of thyroid tissue.
• Hypoplastic thyroid – an under‑developed gland.

Dyshormonogenesis (≈15% of cases)

• Inherited defects in enzymes required for hormone synthesis (e.g., TPO, DUOX2, SLC5A5).
• Often autosomal recessive, leading to a family history of hypothyroidism.

Transient Causes

• Maternal iodine deficiency or excess (iodine is crucial for thyroid hormone production).
• Maternal antithyroid medication (e.g., propylthiouracil) taken during pregnancy.
• Maternal antibodies that cross the placenta and temporarily block the fetal thyroid.

Risk Factors

• Family history of congenital hypothyroidism or other thyroid disorders.
• Consanguineous (related) parents – higher likelihood of autosomal recessive dyshormonogenesis.
• Maternal exposure to radiation or iodine‑containing contrast agents during pregnancy.
• Geographic areas with endemic iodine deficiency (e.g., certain mountainous regions).

Diagnosis

Early diagnosis is critical. In countries with universal screening, CH is usually detected within the first 48–72 hours of life.

Newborn Screening Test

• Primary TSH (thyroid‑stimulating hormone) assay – a heel‑stick blood sample is collected on a filter paper card. Elevated TSH (>20 µIU/mL) suggests hypothyroidism.
• If TSH is high, a second confirmatory test measuring free T4 is performed.

Confirmatory Testing

• Serum TSH and free T4 – definitive diagnosis requires a high TSH (>10 µIU/mL) and low free T4.
• Thyroid ultrasound – evaluates the size, location, and anatomy of the gland.
• Radionuclide thyroid scan (Technetium‑99m or Iodine‑123) – determines functional tissue, especially useful for ectopic glands.
• Genetic testing may be indicated when dyshormonogenesis is suspected or when there is a strong family history.

Additional Laboratory Evaluation

• Serum cholesterol (often elevated in untreated CH).
• Baseline liver function tests if medication (levothyroxine) is initiated.

Treatment Options

The goal of therapy is to replace missing thyroid hormone, thereby normalizing metabolism and supporting normal brain development.

Medication

• Levothyroxine (LT4) – the standard of care; a synthetic form of T4. Initial dose for full‑term infants is 10–15 µg/kg/day (≈15–20 µg/kg/day for premature infants), administered orally.
• Doses are adjusted based on repeat serum TSH and free T4 levels at 1‑ and 2‑week intervals until stable, then every 6‑12 months.
• Compliance is essential; tablets should be taken on an empty stomach, ideally 30 minutes before feeding.

Procedures

• If the thyroid gland is ectopic and symptomatic (e.g., causing airway obstruction), surgical removal may be required, but this is rare.
• In cases of large goiters causing compression, thyroidectomy might be considered after hormone levels are normalized.

Lifestyle and Supportive Measures

• Ensure adequate iodine intake through diet (iodized salt, dairy, fish) once the child is older; excess iodine should be avoided.
• Regular growth monitoring (weight, length/height, head circumference).
• Early intervention services – speech therapy, occupational therapy, and developmental pediatric assessment.
• Family education on medication administration and signs of over‑ or under‑treatment.

Living with Quincy disease (Congenital Hypothyroidism)

With proper treatment, children with CH lead healthy, active lives. Below are practical tips for families and caregivers.

Medication Management

• Use a dedicated pill organizer and set daily alarms.
• Never chew or crush levothyroxine tablets; keep them separate from vitamins or antacids.
• Carry an emergency dose of medication when traveling.

Growth & Development Monitoring

• Schedule pediatric visits every 1–3 months during the first year, then every 6 months.
• Track milestones using tools such as the CDC’s Developmental Checklist.
• Report any regression in language, motor skills, or feeding promptly.

School & Social Life

• Provide the child’s school nurse with a medication schedule.
• Children generally do not need special accommodations once euthyroid, but a statement from the pediatric endocrinologist can be helpful.
• Encourage participation in sports and activities; levothyroxine does not limit performance.

Psychological Support

• Parents may experience anxiety about long‑term outcomes; counseling or support groups (e.g., American Thyroid Association’s patient network) can be valuable.
• Screen for learning difficulties, especially if treatment was started after the first month of life.

Prevention

Because many cases are congenital and unrelated to modifiable factors, true prevention is limited. However, the following steps can reduce the risk of transient or inherited forms:

• Ensure adequate maternal iodine intake before and during pregnancy (150 µg/day for adults; WHO recommendations).
• Avoid unnecessary exposure to maternal antithyroid medications; if needed, use the lowest effective dose under specialist supervision.
• Genetic counseling for families with a history of dyshormonogenesis, especially in populations with high rates of consanguinity.
• Maintain robust newborn screening programs – early detection is the most effective “preventive” measure against irreversible sequelae.

Complications

If congenital hypothyroidism remains untreated or is inadequately treated, serious complications can develop:

• Neurodevelopmental impairment – reduced IQ, learning disabilities, and motor delays.
• Growth failure – short stature and delayed bone age.
• Myxedematous coma (rare in infants, more common in adults) – severe hypothyroidism leading to hypothermia, bradycardia, and altered mental status.
• Hypercholesterolemia and increased cardiovascular risk later in life if hormone levels are not optimal.
• Dental problems – delayed tooth eruption and malocclusion.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention (CDC). Newborn Screening for Congenital Hypothyroidism. 2022.
• Mayo Clinic. Congenital hypothyroidism. 2023. https://www.mayoclinic.org
• American Thyroid Association. Guidelines for the Treatment of Congenital Hypothyroidism. Thyroid. 2021.
• World Health Organization (WHO). Iodine status worldwide. 2021.
• Cleveland Clinic. Congenital hypothyroidism – Symptoms, diagnosis, treatment. 2022.
• NIH National Institute of Child Health and Human Development. Thyroid Disorders in Children. 2023.

```